Clinical Trial Update: Stem Cell Mobilization to Treat Chest Pain and Shortness of Breath in Patients With Coronary Artery Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating stem cell mobilization to treat chest pain and shortness of breath in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Stem cell mobilization therapy

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED